Clinical Trials
12 trialsNCT05651178 2026-06-04
Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients
Hrain Biotechnology Co., Ltd.
Phase EARLY_PHASE1 Active not recruiting
NCT07621471 2026-06-02
IL-15 Enhanced NK Cell Therapy for Solid Tumors
Genovn Therapeutics PTE. LTD.
Phase EARLY_PHASE1 Not yet recruiting
NCT07123662 2026-05-28
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Withdrawn
NCT07196111 2026-05-28
BAFFR CAR-T Treatment for Relapsed/Refractory B-cell Tumors
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Withdrawn
NCT07205315 2026-05-27
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia
Grit Biotechnology
Phase EARLY_PHASE1 Recruiting
NCT04541108 2026-05-22
Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies
Presage Biosciences
Phase EARLY_PHASE1 Active not recruiting
NCT06097962 2026-05-20
Safety and Efficacy of NK510 to Treat NSCLC
Base Therapeutics (Shanghai) Co., Ltd.
Phase EARLY_PHASE1 Recruiting
NCT06959563 2026-05-20
9vHPV-BCG
Medicine Invention Design, Inc
Phase EARLY_PHASE1 Active not recruiting
NCT07595237 2026-05-19
A IIT Study of 177Lu-DOTA-SNA040
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT07597759 2026-05-19
Phase IIT Trial of SNA009
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT07597772 2026-05-19
Preliminary Trial of SNA014 for Pancreatic Cancer
SmartNuclide Biopharma
Phase EARLY_PHASE1 Recruiting
NCT06400485 2026-05-18
AMT-676 in Patients With Advanced Solid Tumors
Multitude Therapeutics Inc.
Phase EARLY_PHASE1 Recruiting